Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

3D imaging effectively tracks skin changes in vitiligo treatment.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

17β-estradiol can reduce inflammation in the skin.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Axitinib treatment turned a man's grey hair back to black.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

ISX9 helps regrow hair by activating a specific cell signaling pathway.